These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19903684)

  • 1. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Stenestrand U; James SK; Lindbäck J; Fröbert O; Carlsson J; Scherstén F; Nilsson T; Lagerqvist B;
    Eur Heart J; 2010 Jan; 31(2):177-86. PubMed ID: 19903684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
    James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
    N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Lagerqvist B; Carlsson J; Fröbert O; Lindbäck J; Scherstén F; Stenestrand U; James SK;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):401-8. PubMed ID: 20031749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
    Lagerqvist B; James SK; Stenestrand U; Lindbäck J; Nilsson T; Wallentin L;
    N Engl J Med; 2007 Mar; 356(10):1009-19. PubMed ID: 17296822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
    Juwana YB; Rasoul S; Ottervanger JP; Suryapranata H
    J Invasive Cardiol; 2010 Jul; 22(7):312-6. PubMed ID: 20603502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of drug-eluting stents in Ontario.
    Tu JV; Bowen J; Chiu M; Ko DT; Austin PC; He Y; Hopkins R; Tarride JE; Blackhouse G; Lazzam C; Cohen EA; Goeree R
    N Engl J Med; 2007 Oct; 357(14):1393-402. PubMed ID: 17914040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes after drug eluting stent implantation in women with de novo coronary lesions. Results from the REAL (REgistro Regionale AngiopLastiche Emilia-Romagna) multicenter registry.
    Ortolani P; Solinas E; Guastaroba P; Casella G; Manari A; Piovaccari G; Balducelli M; Tondi S; Percoco G; Tarantino F; Passerini F; Rossi R; Vignali L; De Palma R; Grilli R; Marzocchi A
    Int J Cardiol; 2011 May; 149(1):55-62. PubMed ID: 20060183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
    Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
    J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents for the treatment of acute myocardial infarction: the view to the HORIZONS.
    Prasad SB; Ahmar W; Malaiapan Y; Meredith IT
    Heart Lung Circ; 2010 Jan; 19(1):11-8. PubMed ID: 20022808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
    Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
    Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.